Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2021-12-10 Regulatory Filings
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance notification under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) regarding the loss of share certificates by shareholders. It is addressed to stock exchanges and requests caution to prevent trading in the lost certificates. The content is regulatory in nature, informing about a specific event related to share certificates, but it does not contain financial data, management discussion, or detailed report content. It is not an annual report, earnings release, or any financial statement. It is also not a voting result, capital change, or director dealing. The document fits best under Regulatory Filings (RNS) as it is a compliance announcement related to regulatory obligations without substantive financial or management report content.
2021-12-10 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) dated 3 December 2021. It contains detailed voting results and proceedings of a Postal Ballot process conducted by the company Hester Biosciences Limited. The document references the Postal Ballot Notice dated 28 October 2021 and includes the declaration of voting results, scrutinizer's report, and detailed tabular data on votes polled for various resolutions. The content is focused on the official announcement of voting outcomes from a shareholder postal ballot, which is a formal declaration of voting results. It does not contain financial statements, management discussion, or other report content. The document is not a proxy solicitation or AGM presentation but specifically the official declaration of voting results as per SEBI regulations. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support a high confidence in this classification.
2021-12-03 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance notice under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the loss of share certificates by shareholders. It requests caution to prevent trading in the lost certificates. The content is a regulatory announcement related to share certificate loss and does not contain financial data, management discussion, or report publication. It is not a financial report, earnings release, or management information. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication.
2021-11-23 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance notification under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchanges about the loss of share certificates by a shareholder. It requests caution to prevent trading in the lost certificates. The document is short (1297 characters) and serves as a regulatory announcement rather than a financial report or detailed filing. It does not contain financial data, management discussion, or meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-11-22 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 13 November 2021 addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting. The content specifically informs about the Board's approval of borrowings by way of External Commercial Borrowing (ECB) for USD 12 million. There is no detailed financial data, no full report, and the document is brief (1288 characters). It is an update on financing activity approved by the Board, which fits the category of Capital/Financing Update (CAP). It is not a full financial report, audit, or earnings release, nor is it a regulatory filing or announcement of a report publication. Therefore, the best classification is Capital/Financing Update (CAP).
2021-11-13 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled Board Meeting to consider borrowings for capital expenditure and investment. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosures about board meetings. The document does not contain financial data, results, or detailed reports but is an announcement of a board meeting. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and does not contain a report itself, so it is not a report publication or regulatory filing. Confidence is high due to clear regulatory reference and content.
2021-11-10 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.